Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing

SIMPLE SUMMARY: Circulating tumor DNA (ctDNA) is a minimally invasive biomarker useful for monitoring minimum residual disease, recurrence, and treatment response in colorectal cancer (CRC). We analyzed circulating tumor DNA from patients with CRC to evaluate analytical and clinical performances usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chul Seung, Kim, Hoon Seok, Schageman, Jeoffrey, Lee, In Kyu, Kim, Myungshin, Kim, Yonggoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391973/
https://www.ncbi.nlm.nih.gov/pubmed/34439344
http://dx.doi.org/10.3390/cancers13164190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391973/
https://www.ncbi.nlm.nih.gov/pubmed/34439344
http://dx.doi.org/10.3390/cancers13164190

Ejemplares similares